PIEZO1 and Alzheimer disease: Our work not only shows that TMAS is advantageous for the treatment of brain aging and neurodegenerative diseases but also provides new insight into the mechanism by which Piezo1 transforms TMAS-related mechanical and electrical stimuli into biochemical signals and identifies Piezo1 as a novel therapeutic target for AD.